OpenVSafe by OpenVAERS
Search V-safe

EN7-10690-41445

1 vaccination 2 coded responses 4 check-ins 2 free-text entries 1 call case
Sex
—
Age at first dose
46-50
ZIP prefix
787 / TX
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
N/A

Timeline

  1. 2020-12-17
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-18
    Registered in v-safe
  3. 2020-12-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-02
    Survey response — day 14, dose 1
    MedDRA: Cough, Fatigue, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue, runny nose, dry cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-02
    Report sent to call center — day 14, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-12-19
    Survey response — 12 months, dose 1
    MedDRA: Pregnancy — Feeling: Good
    Free text: Pregnancy
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-17Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-02

Symptoms: Fatigue, runny nose, dry cough

Release 10 — 12 months, dose 1

2021-12-19

Symptoms: Pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDPregnancy · · ✓
SDRhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release